Cellebrite DI (NASDAQ:CLBT – Free Report) had its price target hoisted by JPMorgan Chase & Co. from $12.00 to $14.00 in a research report sent to investors on Friday, Benzinga reports. The firm currently has an overweight rating on the stock. Several other analysts have also commented on CLBT. Needham & Company LLC raised their […]

Related Keywords

United States , America , Craig Hallum , William Blair , Voss Capital , Jpmorgan Chase Co , Scalar Gauge Management , Needham Company , Acadian Asset Management , Pembroke Management , Cellebrite Di Ltd , Cellebrite Di Company Profile , Free Report , Street Capital , Get Free Report , Asset Management , Middle East ,